SANUWAVE Health, Inc. SNWV
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 1.25% | -26.54% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 1.25% | -26.54% | |||
| Cost of Revenue | 5.80% | -35.50% | |||
| Gross Profit | -0.09% | -23.41% | |||
| SG&A Expenses | -10.77% | -48.36% | |||
| Depreciation & Amortization | 2.03% | -15.75% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.74% | -54.07% | |||
| Operating Income | 75.09% | -140.19% | |||
| Income Before Tax | 53.02% | -123.23% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 52.61% | -123.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 52.61% | -123.56% | |||
| EBIT | 75.09% | -140.19% | |||
| EBITDA | 103.98% | -123.87% | |||
| EPS Basic | 52.66% | -123.51% | |||
| Normalized Basic EPS | 53.10% | -110.29% | |||
| EPS Diluted | 52.24% | -882.71% | |||
| Normalized Diluted EPS | 53.10% | -110.56% | |||
| Average Basic Shares Outstanding | 0.12% | 0.21% | |||
| Average Diluted Shares Outstanding | 0.12% | -2.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||